|
US20020164350A1
(en)
|
1992-09-03 |
2002-11-07 |
Lowy Douglas R. |
Chimeric papillomavirus-like particles
|
|
US8062642B1
(en)
|
1993-03-09 |
2011-11-22 |
University Of Rochester |
Production of papillomavirus capsid protein and virus-like particles
|
|
DE122007000092I1
(de)
*
|
1994-10-07 |
2008-03-27 |
Univ Loyola Chicago |
Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung
|
|
WO1998002548A2
(en)
*
|
1996-07-17 |
1998-01-22 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Infectious papillomavirus pseudoviral particles
|
|
DE19631357A1
(de)
*
|
1996-08-02 |
1998-02-05 |
Deutsches Krebsforsch |
Vektor zur Aktivierung des Immunsystems gegen mit Papillomviren bzw. Sequenzen davon assoziierten Zellen
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
JP2001507352A
(ja)
*
|
1996-12-20 |
2001-06-05 |
メルク エンド カンパニー インコーポレーテッド |
組換えパピローマウイルスワクチンの組成物
|
|
EP1000157A1
(en)
*
|
1997-07-03 |
2000-05-17 |
University Technology Corporation |
Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
|
|
US7351533B2
(en)
*
|
1997-09-05 |
2008-04-01 |
Medimmune, Inc. |
In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
|
|
AU2003200653B2
(en)
*
|
1997-10-06 |
2007-01-18 |
Loyola University Of Chicago |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US6228368B1
(en)
*
|
1997-10-06 |
2001-05-08 |
Loyola University Of Chicago |
Papilloma virus capsomere formulations and method of use
|
|
US7182947B2
(en)
*
|
1998-02-20 |
2007-02-27 |
Medigene Ag |
Papillomavirus truncated L1 protein and fusion protein constructs
|
|
CA2229955C
(en)
|
1998-02-20 |
2003-12-09 |
Medigene Gmbh |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US20020039584A1
(en)
|
1998-02-20 |
2002-04-04 |
Medigene Ag |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US7494658B2
(en)
*
|
1998-02-20 |
2009-02-24 |
Medigene Ag |
Papilloma virus truncated L1 protein and fusion protein constructs
|
|
US6926897B1
(en)
|
1998-03-24 |
2005-08-09 |
Medigene Aktiengesellschaft |
Medicament for the avoidance or treatment of papillomavirus-specific tumour
|
|
DE19812940A1
(de)
*
|
1998-03-24 |
1999-10-07 |
Medigene Ag |
Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
|
|
GB9806666D0
(en)
*
|
1998-03-27 |
1998-05-27 |
Stanley Margaret |
Antigen preparation and use
|
|
US6991795B1
(en)
*
|
1998-08-14 |
2006-01-31 |
Merck & Co., Inc. |
Protein delivery system using human papillomavirus virus-like particles
|
|
CA2339324C
(en)
*
|
1998-08-14 |
2011-05-31 |
Robert S. Lowe |
Protein delivery system using human papillomavirus virus-like particles
|
|
IL142395A0
(en)
|
1998-10-16 |
2002-03-10 |
Smithkline Beecham Biolog |
Adjuvant systems and vaccines
|
|
SE514982C2
(sv)
*
|
1999-09-30 |
2001-05-28 |
Active Biotech Ab |
Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
|
|
DE19925199A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
US20040146531A1
(en)
*
|
1999-09-30 |
2004-07-29 |
Active Biotech Ab |
Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
|
|
US6908613B2
(en)
*
|
2000-06-21 |
2005-06-21 |
Medimmune, Inc. |
Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
|
|
AU2001275438A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Georgetown University |
Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
DE10137102A1
(de)
*
|
2001-07-30 |
2003-02-27 |
Deutsches Krebsforsch |
Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB0206360D0
(en)
*
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
US9045727B2
(en)
*
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
WO2004042001A2
(en)
*
|
2002-05-17 |
2004-05-21 |
Emory University |
Virus-like particles, methods of preparation, and immonogenic compositions
|
|
SI1506222T1
(sl)
*
|
2002-05-17 |
2009-10-31 |
Universty Of Cape Town |
Himerni L1-proteini humanega papilomavirusa 16, ki obsegajo L2-peptid, delci, podobni virusu, pripravljeni iz njih, in postopek za pripravo delcev
|
|
US7858098B2
(en)
*
|
2002-12-20 |
2010-12-28 |
Glaxosmithkline Biologicals, S.A. |
Vaccine
|
|
US20080160040A1
(en)
*
|
2004-04-15 |
2008-07-03 |
Ghim Shin-Je |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
US7972776B2
(en)
*
|
2005-11-15 |
2011-07-05 |
Oncohealth Corporation |
Protein chips for HPV detection
|
|
US7732166B2
(en)
*
|
2005-11-15 |
2010-06-08 |
Oncohealth Corporation |
Detection method for human pappilomavirus (HPV) and its application in cervical cancer
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US8778351B2
(en)
|
2006-08-30 |
2014-07-15 |
University Of Rochester |
Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
|
|
CN101148661B
(zh)
*
|
2006-09-18 |
2013-01-02 |
中国医学科学院基础医学研究所 |
人乳头瘤病毒16型外壳蛋白病毒样颗粒及其制备方法和用途
|
|
AU2007354917B2
(en)
|
2006-09-26 |
2013-06-06 |
Access To Advanced Health Institute |
Vaccine composition containing synthetic adjuvant
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US8968995B2
(en)
*
|
2008-11-12 |
2015-03-03 |
Oncohealth Corp. |
Detection, screening, and diagnosis of HPV-associated cancers
|
|
US8278056B2
(en)
*
|
2008-06-13 |
2012-10-02 |
Oncohealth Corp. |
Detection of early stages and late stages HPV infection
|
|
WO2008115631A2
(en)
*
|
2007-02-08 |
2008-09-25 |
University Of Louisville Research Foundation, Inc. |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
ES2609418T3
(es)
|
2007-03-02 |
2017-04-20 |
Glaxosmithkline Biologicals Sa |
Procedimiento novedoso y composiciones
|
|
EP2154147B1
(en)
|
2007-04-29 |
2015-10-07 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
A truncated l1 protein of human papillomavirus 16
|
|
US9364529B2
(en)
|
2007-04-29 |
2016-06-14 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
Truncated L1 protein of human papillomavirus type 18
|
|
BRPI0810951B8
(pt)
*
|
2007-05-29 |
2021-05-25 |
Beijing Wantai Biological Pharmacy Entpr Co Ltd |
proteína l1 do hpv6, polinucleotídeo, vetor, célula, partícula semelhante ao vírus (vlp) hpv6, método para produzir a proteína hpv6 l1 truncada, vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína hpv6 l1 truncada, método para prevenção de condiloma acuminado ou infecções por hpv, método para obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv
|
|
CA2703066A1
(en)
*
|
2007-10-22 |
2009-04-30 |
University Of Rochester |
Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
|
|
US8795676B2
(en)
*
|
2007-11-23 |
2014-08-05 |
Shanghai Zerun Biotechnology Co., Ltd. |
Genes encoding major capsid protein L1 of human papilloma virus
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
GB0820822D0
(en)
|
2008-11-13 |
2008-12-24 |
Inst Catala D Oncologia |
Novel product and processes
|
|
CN102449479B
(zh)
|
2009-05-07 |
2015-11-25 |
安科健康公司 |
鉴别高度或≥cin2用于人乳头瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
|
|
JP5830015B2
(ja)
|
2009-06-05 |
2015-12-09 |
インフェクシャス ディズィーズ リサーチ インスティチュート |
合成グルコピラノシル脂質アジュバント
|
|
US9128094B2
(en)
|
2010-01-08 |
2015-09-08 |
Oncohealth Corp. |
High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
|
|
AU2012243039B2
(en)
|
2011-04-08 |
2017-07-13 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
WO2012174220A1
(en)
*
|
2011-06-14 |
2012-12-20 |
Globeimmune, Inc. |
Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
|
|
CA2834618C
(en)
|
2011-06-24 |
2020-11-03 |
Merck Sharp & Dohme Corp. |
Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
|
|
EA027511B1
(ru)
|
2011-09-08 |
2017-08-31 |
ЮНИКЬЮРЕ АйПи Б.В. |
Способ отделения популяции парвовирусных вирионов от популяции бакуловирусных вирионов
|
|
SI2811981T1
(sl)
|
2012-02-07 |
2019-08-30 |
Infectious Disease Research Institute |
Izboljšanje adjuvantne formulacije, ki obsegajo TLR4 agoniste in postopki za uporabo le-teh
|
|
WO2013139744A1
(en)
|
2012-03-18 |
2013-09-26 |
Glaxosmithkline Biologicals S.A. |
Method of vaccination against human papillomavirus
|
|
BR112014028476A2
(pt)
|
2012-05-16 |
2017-08-01 |
Immune Design Corp |
fragmento imunogênico de um polipeptídeo, polinucleotídeo isolado, composição farmacêutica imunogênica, métodos para tratar uma infecção, para gerar uma resposta imune em um sujeito, e para imunizar um sujeito
|
|
WO2014172637A1
(en)
|
2013-04-18 |
2014-10-23 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
CN104231060B
(zh)
*
|
2013-06-05 |
2018-05-15 |
厦门大学 |
人乳头瘤病毒l1l2衣壳蛋白相互作用位点及其应用
|
|
IL310015B1
(en)
|
2013-12-31 |
2025-10-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
KR102392974B1
(ko)
|
2016-05-16 |
2022-05-02 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
Tlr 작용제를 함유하는 제제 및 사용 방법
|
|
MX2018013640A
(es)
|
2016-05-16 |
2019-08-01 |
Infectious Disease Res Inst |
Liposomas pegiladas y metodos de uso.
|
|
MX385732B
(es)
|
2016-06-01 |
2025-03-18 |
Infectious Disease Res Inst |
Partículas de nanoalumbre que contienen un agente de dimensionamiento.
|
|
JP2020524143A
(ja)
|
2017-06-15 |
2020-08-13 |
インフェクシャス ディズィーズ リサーチ インスティチュート |
ナノ構造脂質担体、安定エマルジョン、およびその使用
|
|
EP3678695A1
(en)
|
2017-09-08 |
2020-07-15 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
WO2020139843A1
(en)
*
|
2018-12-28 |
2020-07-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Engineered hepatitis b core polypeptide
|
|
BR112021023726A2
(pt)
|
2019-05-25 |
2022-02-15 |
Infectious Disease Res Inst |
Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante
|
|
CN114127099B
(zh)
*
|
2019-07-19 |
2024-04-19 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒6型l1蛋白
|
|
CN114127097B
(zh)
*
|
2019-07-19 |
2024-09-17 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒56型l1蛋白
|
|
WO2021013063A1
(zh)
*
|
2019-07-19 |
2021-01-28 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒16型l1蛋白
|
|
AU2020317321B2
(en)
|
2019-07-19 |
2023-07-27 |
Sinocelltech Ltd. |
Polyvalent immunogenicity composition for human papillomavirus
|
|
JP7805920B2
(ja)
*
|
2019-07-19 |
2026-01-26 |
神州細胞工程有限公司 |
キメラパピローマウイルスｌ１タンパク質
|
|
AU2021219652A1
(en)
|
2020-02-14 |
2022-08-18 |
Merck Sharp & Dohme Llc |
HPV vaccine
|
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
CN114539365B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种改造的人乳头瘤病毒52型l1蛋白及其用途
|
|
CN114539363B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种c端改造的人乳头瘤病毒11型l1蛋白及其用途
|
|
CA3210363A1
(en)
|
2021-02-11 |
2022-08-18 |
Glaxosmithkline Biologicals Sa |
Hpv vaccine manufacture
|
|
WO2022268811A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
WO2023014853A1
(en)
|
2021-08-06 |
2023-02-09 |
Merck Sharp & Dohme Llc |
Hpv vaccine
|
|
TW202315602A
(zh)
|
2021-08-19 |
2023-04-16 |
美商默沙東有限責任公司 |
新穎熱穩定脂質奈米粒子及其使用方法
|
|
CA3266697A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
COMPOSITION OF AN IMMUNOGENEOUS VACCINE CONTAINING A SAPONIN
|
|
AR132886A1
(es)
|
2023-06-09 |
2025-08-06 |
Merck Sharp & Dohme Llc |
Composiciones adyuvantes en nanoemulsión para vacunas contra el papilomavirus humano
|